The Toronto Blue Jays have brought back veteran pitcher Max Scherzer on a one-year contract, bolstering their rotation for the 2026 season. The deal, first reported by Jon Heyman of The Novel York Post, guarantees Scherzer $3 million with the potential to earn up to $10 million in incentives. This move signals the Blue Jays’ continued commitment to contention as they aim to build on their recent playoff appearances and finally break through to a World Series championship.
Scherzer’s return provides a familiar face and a wealth of experience to a pitching staff navigating some early-season challenges. With Shane Bieber expected to begin the year on the injured list due to forearm fatigue sustained during the playoffs, the Blue Jays needed to add depth and reliability. Scherzer, despite a less-than-stellar 2024 campaign, offers both. The signing pushes Toronto’s franchise-record luxury tax payroll to approximately $319 million, according to RosterResource, incurring a $2.7 million base tax.
Navigating Scherzer’s 2024 Performance and Health
Last season, Scherzer posted a 5.19 ERA over 85 innings pitched, marking the first time in his illustrious 17-year career he allowed more than five earned runs per nine innings. While his fastball velocity remained solid, averaging 93.6 mph – a slight increase from his 2024 mark – he struggled with home run ball, allowing more than two per nine innings, the fourth-highest rate in MLB among pitchers with at least 70 innings pitched. His issues stemmed from a nerve issue in his throwing arm, which initially surfaced during his time with the Texas Rangers and resurfaced after joining the Blue Jays.
Scherzer’s debut with Toronto was cut short after just three innings due to thumb soreness related to the nerve issue, sidelining him for a significant portion of the season. He didn’t return to the mound until late June. Despite avoiding another injured list stint, he didn’t consistently perform to his usual standards, with only six quality starts in 17 appearances. But, he did demonstrate his ability to perform in high-leverage situations, contributing in both the AL Championship Series against the Seattle Mariners and the World Series against the Los Angeles Dodgers. He earned a win in Game 4 of the ALCS, tossing 5 2/3 innings of two-run ball, and pitched effectively in Game 7 of the World Series, allowing one run over 4 1/3 innings, though the Blue Jays ultimately fell short.
Rotation Implications and Bullpen Adjustments
Assuming Scherzer is fully healthy and builds up for the start of the season, he is likely to slot into a six-man rotation alongside Dylan Cease, Kevin Gausman, José Berríos, Cody Ponce, and the injured Shane Bieber. This approach aims to manage the workload on the rotation, particularly after a demanding playoff push in 2024. The Blue Jays’ starting five was originally slated to include Cease, Gausman, Yesavage, Berríos, and Ponce, but Bieber’s injury and Scherzer’s signing have altered those plans.
However, utilizing a six-man rotation will necessitate a reduction in bullpen size, limiting the Blue Jays to seven relief pitchers due to MLB’s 13-pitcher limit. This places increased importance on having a reliable long reliever, such as Eric Lauer, capable of handling multiple innings. Lauer, an impending free agent, reportedly prefers a starting role and believes his time in the bullpen last season negatively impacted his arbitration outcome, losing his hearing and receiving a $4.4 million salary instead of his requested $5.75 million, as reported by Mitch Bannon of The Athletic.
Financial Considerations and Future Outlook
The Blue Jays’ commitment to Scherzer comes with a significant financial cost. The $3 million base salary, coupled with the potential for $10 million in incentives, adds to an already substantial payroll. The team is now taxed at a 90% rate on spending exceeding $304 million, with this signing adding a $2.7 million base tax. Any performance bonuses Scherzer earns will also be subject to the 90% tax rate.
Despite his age (41) and recent struggles, Scherzer remains a capable pitcher who can still miss bats, striking out 23% of batters faced with a 6.4% walk rate. His experience and ability to deliver in crucial moments produce him a valuable addition to the Blue Jays’ roster. The team will be closely monitoring his health and performance as they look to contend in the American League East.
The Blue Jays will now focus on spring training and preparing for the 2026 season. The development of young pitchers like Trey Yesavage will be crucial, as will the continued health of key players like Bieber and Gausman. The team’s success will depend on Scherzer’s ability to regain his form and contribute consistently to the rotation. The next confirmed checkpoint will be observing Scherzer’s performance during spring training games and his readiness for Opening Day.
What are your thoughts on the Blue Jays re-signing Max Scherzer? Share your opinions in the comments below and be sure to share this article with fellow baseball fans!
